JPRN-UMIN000033806
Recruiting
Phase 1
Blood biomarker of colorectal adenoma and early-stage adenocarcinoma - Blood biomarker of colorectal tumor
Fujita Health University School of Medicine, Department of Gastroenterology0 sites200 target enrollmentAugust 19, 2018
Overview
- Phase
- Phase 1
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Fujita Health University School of Medicine, Department of Gastroenterology
- Enrollment
- 200
- Status
- Recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
Enrollent is ongoing.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1\. Pregnant women 2\. Patients with small and large bowel stricture 3\. inappropriate patients to enroll judged by doctors
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Phase 2
Biomarker analysis in advanced colorectal cancer patients treated with mFOLFOX6 plus bevacizumab or XELOX plus bevacizumabJPRN-UMIN000012442West Japan Oncology Group100
Completed
Not Applicable
Serum Proteomic Profiling for the Early Diagnosis of Colorectal CancerColorectal NeoplasmsNCT01604798Fudan University547
Recruiting
Not Applicable
Use of Blood Biomarkers for the Early Diagnosis of Hepatocellular Carcinoma (HCC)HCCCirrhosis, LiverNAFLDHBVHCVNCT05781568Azienda Ospedaliera Specializzata in Gastroenterologia Saverio de Bellis60
Active, not recruiting
Not Applicable
Use of ctDNA for Monitoring of Stage III Colorectal CancerStage III Colorectal CancerNCT02842203University of Pittsburgh137
Unknown
Not Applicable
Fecal Immunochemical Test for Advanced Adenoma Detection in Colorectal Cancer ScreeningColorectal CancerColorectal NeoplasmsColorectal AdenomaNCT05200611Shandong University5,000